Fever, Sweats, and Hot Flashes (PDQ®): Supportive care - Patient Information [NCI] - Overview
Fever, sweats, or hot flashes may be side effects of cancer or its treatment.In patients with cancer, fever may be caused by infection, a tumor, or reactions to drugs or blood transfusions. Sweating is the body's way of lowering body temperature by causing heat loss through the skin. In patients with cancer, sweating may be caused by fever, a tumor, or cancer treatment.Hot flashes can also cause too much sweating. They may occur in natural menopause or in patients who have been treated for breast cancer or prostate cancer. Fever, sweats, and hot flashes affect quality of life in many patients with cancer. A treatment plan to help manage fever, sweats, or hot flashes is based on the patient's condition and goals of care. For some patients, relieving symptoms and improving quality of life is a more important goal than treating the fever to prolong life.This summary describes the causes and treatment of fever, sweats, and hot flashes in cancer patients.
Lung Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - Lung Cancer Prevention
Avoiding risk factors and increasing protective factors may help prevent lung cancer.Avoiding cancer risk factors may help prevent certain cancers. Risk factors include smoking, being overweight, and not getting enough exercise. Increasing protective factors such as quitting smoking, eating a healthy diet, and exercising may also help prevent some cancers. Talk to your doctor or other health care professional about how you might lower your risk of cancer.The following are risk factors for lung cancer:Cigarette, cigar, and pipe smoking Tobacco smoking is the most important risk factor for lung cancer. Cigarette, cigar, and pipe smoking all increase the risk of lung cancer. Tobacco smoking causes about 9 out of 10 cases of lung cancer in men and about 8 out of 10 cases of lung cancer in women.Studies have shown that smoking low tar or low nicotine cigarettes does not lower the risk of lung cancer. Studies also show that the risk of lung cancer from smoking cigarettes increases with the
Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Treatment Option Overview
Successful treatment generally requires the combination of effective systemic chemotherapy and complete resection of all clinically detectable disease. Protective weight bearing is recommended for patients with tumors of weight-bearing bones to prevent pathological fractures that could preclude limb-preserving surgery.Randomized clinical trials have established that both neoadjuvant and adjuvant chemotherapy are effective in preventing relapse in patients with clinically nonmetastatic tumors.[1,2] The Pediatric Oncology Group conducted a study in which patients were randomly assigned either to immediate amputation or amputation after neoadjuvant therapy. A large percentage of patients declined to be assigned randomly, and the study was terminated without approaching the stated accrual goals. In the small number of patients treated, there was no difference in outcome for those who received preoperative versus postoperative chemotherapy. It is imperative that patients with proven or
Paranasal Sinus and Nasal Cavity Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Recurrent Paranasal Sinus and Nasal Cavity Cancer
Recurrent paranasal sinus and nasal cavity cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the paranasal sinuses and nasal cavity or in other parts of the body.
Pheochromocytoma and Paraganglioma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage Information for Pheochromocytoma and Paraganglioma
There is no standard staging system for pheochromocytoma and paraganglioma. Patients have traditionally been divided into one of three categories:Localized (apparently benign) disease.Regional disease.Metastatic disease. The most common sites of metastasis for pheochromocytoma or extra-adrenal paraganglioma are lymph nodes, bones, lungs, and liver.
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®): Treatment - Patient Information [NCI] - nci_ncicdr0000258001-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Childhood Acute Lymphoblastic Leukemia Treatment
Cardiopulmonary Syndromes (PDQ®): Supportive care - Patient Information [NCI] - Current Clinical Trials
Check NCI's list of cancer clinical trials for U.S. supportive and palliative care trials about dyspnea, malignant pleural effusion and malignant pericardial effusion that are now accepting participants. The list of trials can be further narrowed by location, drug, intervention, and other criteria. General information about clinical trials is also available from the NCI Web site.
Last Days of Life (PDQ®): Supportive care - Patient Information [NCI] - Care in the Final Hours
Knowing what to expect in the final days or hours may be comforting to the family.Most people are not familiar with the signs that death is near. Knowing what to expect can prepare them for the death of their loved one and make this time less stressful and confusing. Health care providers can give family members information about the changes they may see in their loved one in the final hours and how they may help their loved one through it. Patients often lose the desire to eat or drink in the final days or hours.In the final days to hours of life, patients often lose the desire to eat or drink, and may refuse food and fluids that are offered to them. The family may give ice chips or swab the mouth and lips to keep them moist. Forcing food and fluids can make the patient uncomfortable or cause choking. Family members may find other ways to show their love for the patient, such as massage.Patients near death may not respond to others.Patients may withdraw and spend more time sleeping.
Smoking in Cancer Care (PDQ®): Supportive care - Patient Information [NCI] - Questions or Comments About This Summary
If you have questions or comments about this summary, please send them to Cancer.gov through the Web site's Contact Form. We can respond only to email messages written in English.
Topics in Complementary and Alternative Therapies (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Pharmacologic Treatments
714-X714-X is a chemical compound that contains camphor, a natural substance that comes from the wood and bark of the camphor tree. Nitrogen, water, and salts are added to camphor to make 714-X. It is claimed that 714-X protects the immune system and helps the body fight cancer. No peer-reviewed studies of 714-X has been published to show that it is safe or effective in treating cancer. See the PDQ patient summary on 714-X for more information.AntineoplastonsAntineoplastons are drugs made of chemical compounds that are naturally present in the urine and blood. It has been claimed that antineoplaston therapy can be used to stop certain cancer cells from dividing, while healthy cells are not affected.See the PDQ patient summary on Antineoplastons for more information.Cancell/Cantron/ProtocelCancell/Cantron/Protocel is a liquid that has been made in different forms since the late 1930s. It is also known by the names Sheridan's Formula, Jim's Juice, JS-114, JS-101, 126-F, and the